KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to 22.42%.

  • Johnson & Johnson's EBITDA Margin rose 64400.0% to 22.42% in Q4 2025 from the same period last year, while for Dec 2025 it was 26.93%, marking a year-over-year increase of 32700.0%. This contributed to the annual value of 26.93% for FY2025, which is 32700.0% up from last year.
  • Per Johnson & Johnson's latest filing, its EBITDA Margin stood at 22.42% for Q4 2025, which was up 64400.0% from 29.31% recorded in Q3 2025.
  • Johnson & Johnson's EBITDA Margin's 5-year high stood at 34.44% during Q1 2023, with a 5-year trough of 15.98% in Q4 2024.
  • For the 5-year period, Johnson & Johnson's EBITDA Margin averaged around 25.44%, with its median value being 26.95% (2023).
  • Examining YoY changes over the last 5 years, Johnson & Johnson's EBITDA Margin showed a top increase of 78200bps in 2023 and a maximum decrease of -145700bps in 2023.
  • Over the past 5 years, Johnson & Johnson's EBITDA Margin (Quarter) stood at 28.31% in 2021, then fell by -6bps to 26.5% in 2022, then fell by -25bps to 19.87% in 2023, then fell by -20bps to 15.98% in 2024, then skyrocketed by 40bps to 22.42% in 2025.
  • Its EBITDA Margin was 22.42% in Q4 2025, compared to 29.31% in Q3 2025 and 27.99% in Q2 2025.